Pharyngitis Therapeutics Market Set to Encounter Paramount Growth with Myriad Advances Appraised By Global Players Genentech Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Pfizer Inc., Valeant Pharmaceuticals International, Inc.
Pharyngitis, commonly referred to as sore throat, causes inflammation of pharynx located behind the throat. Pharyngitis is caused by bacterial or viral infections and cases of pharyngitis are majorly observed in colder months of the year. Measles, adenovirus, chickenpox, croup, whooping cough, and group A streptococcus are the major causes of pharyngitis. Pharyngitis is also commonly caused by viral infections such as common cold, influenza, and mononucleosis. According to the Centers for Disease Control and Prevention (CDC), amoxicillin and penicillin are the most commonly prescribed treatments for sore throat.For In depth Information Get Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/2001
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and acetaminophen are used to reduce the pain associated with pharyngitis. Besides, Aspirin is also used by adults, however, not recommended for children due to risk of occurrence of Reye syndrome.
Pharyngitis Therapeutics Market - Regional Insights
North America accounted for the largest share in the global pharyngitis therapeutics market, followed by Europe market in 2016. This is attributed to increasing prevalence of pharyngitis in North America. According to data published in American Family Physician Journal in 2009, pharyngitis is diagnosed in 11 million people in outpatient settings, each year in the U.S.
Furthermore, several pharmaceutical and biotechnological companies are focusing on expanding in the Asia Pacific region, to maximize their R&D efforts, as the Asia Pacific region provides low capital investment in research and development due to lower operational cost and highly efficient technicians. Increasing government investment in research and development is also expected to foster growth of the pharyngitis therapeutics market in Asia Pacific. As Group A Streptococcus is the most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living conditions. Hence Asia Pacific region provides a high opportunity for drug manufacturers in pharyngitis therapeutics market.
Pharyngitis Therapeutics Market - Competitive Analysis:
Major players operating in the market include Genentech Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Mylan N.V., GSK group of companies, Teva Pharmaceutical Industries Ltd., and AbbVie Inc.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pharyngitis-therapeutics-market-2001
Pharyngitis Therapeutics Market - Taxonomy:
By Source of Infection:
Viral ,Bacterial
By Drug Class:
Antiviral Drugs ,Antibacterial Drugs ,Anti-inflammatory Drugs ,Topical Anesthetics Drugs
By Distribution Channel:
Hospital Pharmacy ,Retail Pharmacy ,Online Pharmacy
By Region:
North America ,Latin America ,Europe ,Asia Pacific ,Middle East ,Africa
Pharyngitis Therapeutics Market Dynamics:
According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious lack of new antibiotics in development, underscoring that antibiotic resistance is a global health emergency set to undermine the decades of progress in modern medicine.
Therefore, manufactures are increasingly focusing on research and development for new discovery of antibiotics or any other therapeutic drugs to treat pharyngitis. For instance, Innovative Med Concepts, Inc. is in the process of developing a promising treatment for pharyngitis i.e the company’s second novel product NRP-1—a proprietary throat spray—is designed to treat viral pharyngitis, which is expected to serve the large unmet medical needs and cause of most cases of pharyngitis. NRP-1 will also provide the required relief for cancer patients undergoing head and neck radiation plagued with disabling oral mucositis/pharyngitis. This spray delivers medication, which then adheres to the posterior pharynx despite repeated swallows and saliva.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2001
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharyngitis Therapeutics Market Set to Encounter Paramount Growth with Myriad Advances Appraised By Global Players Genentech Inc., Adamas Pharmaceutical Inc., PLIVA HRVATSKA d.o.o., Pfizer Inc., Valeant Pharmaceuticals International, Inc. here
News-ID: 1567663 • Views: …
More Releases from Coherent Market Insights
Board Packaging Market Analysis: Insights into Market Dynamics and Future Growth …
The latest report published by Coherent Market Insights highlights the growth prospects of the Board Packaging Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such…
Tankless Water Heater Market Analysis: Growth Factors, Opportunities, Challenges …
The latest report published by Coherent Market Insights highlights the growth prospects of the Tankless Water Heater Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors…
Bispyribac Sodium Market Research Report: Industry Analysis, Size, Share, Growth …
The latest report published by Coherent Market Insights highlights the growth prospects of the Bispyribac Sodium Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such…
Electroplating Market: An Insightful Evaluation of Growth, Demand, Trends, and F …
The global electroplating market is US$ 18.40 Billion in 2022 and projected to reach US$ 27.3 Billion by the end of 2030, in terms of revenue, growing at CAGR of 5.06% during the forecast period (2023 to 2030).
The latest report published by Coherent Market Insights highlights the growth prospects of the Electroplating Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast.…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…